The similar effects have been observed in liver cancer and oesophageal cancer via the signal transducer and activator of transcription 3 (STAT3)‐COX‐2 and JAK2/STAT3 pathway88, 89 (Figure 2). This evidence concerns the gene STAT3 and liver cancer.